Victoria has become the latest Australian jurisdiction to fund BEXSERO, the meningococcal B vaccine produced by GSK, joining South Australia, Queensland and the Northern Territory in offering state-supported access while a national roll‑out remains off the table. …
Victoria joins state-funded MenB programs as PBAC rejection creates another 'postcode lottery'
May 8, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
New Zealand's pre-election Budget boosts health spending, but Pharmac misses out
May 29, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 29 May
May 28, 2026 - - Podcast -
AusBiotech unites conferences under the banner of the 'Biggest Week' in biotech
May 28, 2026 - - Australian Biotech -
Research highlighting gaps leaving some communities at greater risk as flu
May 28, 2026 - - Latest News -
A fraught process but also an opportunity to reintroduce ideas sidelined by the review
May 28, 2026 - - Latest News -
Single infusion of Lilly gene editing cuts cholesterol with the company planning long-term study
May 27, 2026 - - Latest News -
ARCS launches national partnership to boost public clinical research sites
May 27, 2026 - - Latest News